Esteban Corley, Director of mAbxience Argentina (pharmADN) has more than 30 years’ working experience with Biopharmaceuticals. All his career has been devoted to develop, manufacture and market Biosimilar pharmaceuticals to improve access and affordability.
During his professional career he has co-founded several Biotech companies in Argentina and contributed to achieve close collaborations between them and European Biotech companies underlining the international scope of these biotech ventures.
Esteban has also worked for the Argentine Ministry of Science and Technology as the Director of an international cooperation program between the European Union and Mercosur countries
In 2007 Esteban co-founded pharmADN, a company that is an essential member of the mAbxience group, producing monoclonal antibodies.
He is a member of the advising committee for the CABBIO (Argentine-Brazilian Biotechnology center) and a member of the Board of Directors of Biotecsur, Mercosur´s Biotechnology Platform, he is also a member of the Argentine Chamber of Biotechnology.
Esteban holds a degree in Biological Sciences from the University of Buenos Aires, and a Business degree from the Universidad Austral.